Premium
Inhibrx Biosciences Inc (INBX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Viking Global Investors LP | Institution | 1 461 633 | 9,96% | US$ 127,18M | 2026-03-31 |
| Perceptive Advisors LLC | Institution | 1 442 707 | 9,83% | US$ 125,53M | 2026-03-31 |
| Morgan Stanley | Institution | 1 250 441 | 8,52% | US$ 108,80M | 2026-03-31 |
| Sanofi | Institution | 1 157 926 | 7,89% | US$ 100,75M | 2026-03-31 |
| Dr. John Kayyem | Initiés | 1 059 046 | 7,22% | US$ 92,15M | 2025-04-01 |
| Mr. Mark Lappe | Initiés | 925 413 | 6,31% | US$ 80,52M | 2025-04-01 |
| HighTower Advisors, LLC | Institution | 870 200 | 5,93% | US$ 75,72M | 2026-03-31 |
| BlackRock, Inc. | Institution | 798 898 | 5,45% | US$ 69,51M | 2026-03-31 |
| Perceptive Life Sciences Master Fund, Ltd. | Institution | 728 948 | 4,97% | US$ 63,43M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 550 845 | 3,75% | US$ 47,93M | 2026-03-31 |
| Dr. Brendan Eckelman | Initiés | 513 888 | 3,50% | US$ 44,71M | 2025-04-01 |
| Vanguard Capital Management, LLC | Institution | 486 422 | 3,32% | US$ 42,32M | 2026-03-31 |
| Sofinnova Investments, Inc. | Institution | 406 029 | 2,77% | US$ 35,33M | 2026-03-31 |
| Capital Research and Management Company | Institution | 392 847 | 2,68% | US$ 34,18M | 2026-03-31 |
| Woodline Partners LP | Institution | 384 433 | 2,62% | US$ 33,45M | 2026-03-31 |
| Millennium Management LLC | Institution | 327 860 | 2,23% | US$ 28,53M | 2026-03-31 |
| PFM Health Sciences, LP | Institution | 305 431 | 2,08% | US$ 26,58M | 2026-03-31 |
| Schonfeld Strategic Advisors LLC | Institution | 254 827 | 1,74% | US$ 22,17M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 231 509 | 1,58% | US$ 20,14M | 2026-03-31 |
| Mr. Douglas Forsyth | Initiés | 224 564 | 1,53% | US$ 19,54M | 2025-04-01 |
| Healthcare of Ontario Pension Plan Trust Fund | Institution | 170 700 | 1,16% | US$ 14,85M | 2026-03-31 |
| Crestline Investors Inc. | Institution | 137 821 | 0,94% | US$ 11,99M | 2026-03-31 |
| Norges Bank Investment Management | Institution | 133 300 | 0,91% | US$ 11,60M | 2025-12-31 |
| Soleus Capital Management, L.P. | Institution | 131 000 | 0,89% | US$ 11,40M | 2026-03-31 |
| Capitolis Advisors LLC | Institution | 125 000 | 0,85% | US$ 10,88M | 2026-03-31 |
| First Trust Advisors LP | Institution | 124 856 | 0,85% | US$ 10,86M | 2026-05-29 |
| La Caisse de dépôt et placement du Québec | Institution | 124 530 | 0,85% | US$ 10,84M | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 97 873 | 0,67% | US$ 8,52M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 93 696 | 0,64% | US$ 8,15M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 83 450 | 0,57% | US$ 7,26M | 2026-03-31 |
| D. E. Shaw & Co., L.P. | Institution | 77 437 | 0,53% | US$ 6,74M | 2026-03-31 |
| Kennedy Capital Management LLC | Institution | 72 812 | 0,50% | US$ 6,34M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 72 460 | 0,49% | US$ 6,30M | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 64 322 | 0,44% | US$ 5,60M | 2026-03-31 |
| Citigroup Inc. | Institution | 62 516 | 0,43% | US$ 5,44M | 2026-03-31 |
| FMR LLC | Institution | 52 665 | 0,36% | US$ 4,58M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 50 183 | 0,34% | US$ 4,37M | 2026-03-31 |
| UBS Asset Management AG | Institution | 48 204 | 0,33% | US$ 4,19M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
